TG Therapeutics
TGTX
TGTX
330 hedge funds and large institutions have $2.92B invested in TG Therapeutics in 2024 Q4 according to their latest regulatory filings, with 83 funds opening new positions, 98 increasing their positions, 98 reducing their positions, and 55 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
0% more repeat investments, than reductions
Existing positions increased: 98 | Existing positions reduced: 98
3.25% less ownership
Funds ownership: 65.66% → 62.4% (-3.3%)
Holders
330
Holding in Top 10
5
Calls
$137M
Puts
$113M
Top Buyers
| 1 | +$52.7M | |
| 2 | +$47.5M | |
| 3 | +$12.7M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$11.2M |
| 5 |
PCM
Penn Capital Management
Philadelphia,
Pennsylvania
|
+$10.1M |
Top Sellers
| 1 | -$60M | |
| 2 | -$42.1M | |
| 3 | -$40.3M | |
| 4 |
Goldman Sachs
New York
|
-$28.2M |
| 5 |
Pictet Asset Management
Carouge,
Switzerland
|
-$22.6M |